End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.14 CNY | +0.31% | -3.60% | -13.21% |
Jul. 04 | Aodong Medicine Industry's Unit Gets Nod to Register 10 Chinese Traditional Medicines | MT |
May. 23 | Aodong Medicine Industry's Unit Gets Certificates for 10 Traditional Chinese Medicines | MT |
Business Summary
- sale of pharmaceutical products (89.4%);
- sale of food products (6.8%);
- other (3.8%).
All sales are in China.
Number of employees: 5,646
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicine
76.6
%
| 2,150 | 74.9 % | 2,643 | 76.6 % | +22.97% |
Food
11.2
%
| 377 | 13.1 % | 386 | 11.2 % | +2.50% |
Wholesale and Retail of Chain Drug Stores
10.9
%
| 450 | 15.7 % | 377 | 10.9 % | -16.17% |
Other
7.8
%
| 202 | 7.0 % | 268 | 7.8 % | +32.57% |
Inter-segment Elimination
-6.6
%
| -312 | -10.9 % | -227 | -6.6 % | -27.21% |
Group Investment
0.1
%
| 2 | 0.1 % | 2 | 0.1 % | -7.40% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 2,868 | 100.0 % | 3,449 | 100.0 % | +20.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 04-04-30 |
Da Long Zhao
DFI | Director of Finance/CFO | 50 | 99-06-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 52 | 07-06-17 |
Yong Feng Chen
CHM | Chairman | 57 | 00-09-30 |
Ming Jing Zhang
BRD | Director/Board Member | 42 | 17-06-30 |
Zhen Yu Wang
BRD | Director/Board Member | 43 | 04-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xiu Lin Li
CHM | Chairman | 71 | 93-01-31 |
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Yu Ju Sun
BRD | Director/Board Member | 52 | 08-05-05 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 52 | 07-06-17 |
Zhen Yu Wang
BRD | Director/Board Member | 43 | 04-06-30 |
Peng Li
BRD | Director/Board Member | 42 | 20-07-16 |
Da Long Zhao
BRD | Director/Board Member | 50 | 15-12-31 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 04-04-30 |
Ming Jing Zhang
BRD | Director/Board Member | 42 | 17-06-30 |
Wei Wei Xiao
BRD | Director/Board Member | 44 | 20-09-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,241,069,418 | 811,810,642 ( 65.41 %) | 45,174,031 ( 3.640 %) | 65.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GF SECURITIES CO., LTD. 15.95% | 271,448,800 | 15.95% | 224,949,621 $ |
91,500,376 | 5.98% | 105,402,028 $ | |
36,138,251 | 3.12% | 66,645,801 $ |
Company contact information
Jilin Aodong Pharmaceutical Group Co., Ltd.
2158 Aodong Street Dunhua
133700, Yanbian Korean Autonomous Prefecture
+
http://www.jlaod.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.21% | 2.17B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- 000623 Stock
- Company Jilin Aodong Pharmaceutical Group Co., Ltd.